Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant

University of Alberta

$657,494.00

Creatine Supplementation as a treatment of Fatty Liver Disease

EF 2013-14

Résumé
Creatine, a naturally occurring substance, is made in our bodies but can be obtained from the food supply. The major dietary sources of creatine are meat and dairy products. We have made the novel discovery that creatine supplementation reduces the amount of fat in the liver of rodents fed a high fat diet. This finding suggests that creatine may be a treatment for fatty liver diseases. Current data suggest that 20-30% of Canadians have fatty liver diseases which, if left untreated, would represent a significant stress on the health care system. In this proposal, we will determine the mechanism by which creatine prevents fat accumulation in the liver. To accomplish this goal we will use liver cells and various mouse models. The results of this proposal will determine the efficacy of feeding creatine, an inexpensive, safe natural health product, in the treatment of fatty liver diseases. It will provide the experimental evidence to support future clinical trials to treat this serious obesity related disease.
Programme
Operating Grant
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
290717
Name
Jacobs Rene L
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Nutrition, Food & Health
Projecttitle
Creatine Supplementation as a treatment of Fatty Liver Disease
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$657,494
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Cell Culture; Creatine; Dietary Supplementation; High Fat Diet; Lipid Metabolism; Metabolic Flux; Molecular Biology
Abstract
Creatine, a naturally occurring substance, is made in our bodies but can be obtained from the food supply. The major dietary sources of creatine are meat and dairy products. We have made the novel discovery that creatine supplementation reduces the amount of fat in the liver of rodents fed a high fat diet. This finding suggests that creatine may be a treatment for fatty liver diseases. Current data suggest that 20-30% of Canadians have fatty liver diseases which, if left untreated, would represent a significant stress on the health care system. In this proposal, we will determine the mechanism by which creatine prevents fat accumulation in the liver. To accomplish this goal we will use liver cells and various mouse models. The results of this proposal will determine the efficacy of feeding creatine, an inexpensive, safe natural health product, in the treatment of fatty liver diseases. It will provide the experimental evidence to support future clinical trials to treat this serious obesity related disease.
Competitiondate
201309
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Jacobs, Rene L
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $657,494~ $0~